SAB Biotherapeutics (SABS) Selling, General & Administrative (2021 - 2026)
SAB Biotherapeutics (SABS) Selling, General & Administrative (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 555.10 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.47 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 101.25 Mn |
| 10 | SAB Biotherapeutics | 170.64 Mn | 170.64 Mn | - | 6.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.60 Mn |
| Dec 31, 2025 | 5.04 Mn |
| Sep 30, 2025 | 3.71 Mn |
| Jun 30, 2025 | 2.74 Mn |
| Mar 31, 2025 | 3.11 Mn |
| Dec 31, 2024 | 2.47 Mn |
| Sep 30, 2024 | 3.48 Mn |
| Jun 30, 2024 | 3.64 Mn |
| Mar 31, 2024 | 4.19 Mn |
| Dec 31, 2023 | 14.88 Mn |
| Sep 30, 2023 | 2.57 Mn |
| Jun 30, 2023 | 2.90 Mn |
| Mar 31, 2023 | 3.45 Mn |
| Dec 31, 2022 | 2.88 Mn |
| Sep 30, 2022 | 4.04 Mn |
| Jun 30, 2022 | 4.31 Mn |
| Mar 31, 2022 | 5.19 Mn |
| Dec 31, 2021 | 7.75 Mn |
| Sep 30, 2021 | 3.60 Mn |
| Jun 30, 2021 | 2.40 Mn |